Announcements Trials

Browse Landscape

Sponsor

Conditions

Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Multiple Myeloma 1 Melanoma 1 Lymphoma 1 Lung Neoplasms 1 Hematologic Neoplasms 1 Glioma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

Pemetrexed 18 Carboplatin 16 Cisplatin 14 Paclitaxel 9 Gemcitabine 7 pembrolizumab 6 Crizotinib 5 osimertinib 4 amivantamab 4 Nivolumab 4 Docetaxel 4 lazertinib 3 Vinorelbine 3 Ipilimumab 3 Afatinib 3 selpercatinib 2 lorlatinib 2 durvalumab 2 cemiplimab 2 atezolizumab 2 alectinib 2 Gefitinib 2 Albumin-Bound Paclitaxel 2 130-nm albumin-bound paclitaxel 2 zenocutuzumab 1 trastuzumab deruxtecan 1 trametinib 1 tepotinib 1 telisotuzumab vedotin 1 taletrectinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Carcinoma, Non-Small-Cell Lung × omipalisib × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡